Ngā hua rapu - Edwin Alvarez
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
-
2
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis mā Kazuki N. Sugahara, Pablo Scodeller, Gary B. Braun, Tatiana Hurtado de Mendoza, Chisato M. Yamazaki, Michael D. Kluger, Joji Kitayama, Edwin Alvarez, Stephen B. Howell, Tambet Teesalu, Erkki Ruoslahti, Andrew M. Lowy
I whakaputaina 2015Artigo -
3
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial mā Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Anishka D'souza, Irene Braña, François‐Clément Bidard, Jonathan W. Goldman, Edwin Alvarez, Valentina Boni, Adam C. ElNaggar, Rodolfo Passalacqua, Khanh T.M., Alessandro D. Santin, Kiana Keyvanjah, Feng Xu, Lisa D. Eli, Alshad S. Lalani, Richard Bryce, David M. Hyman, Funda Meric‐Bernstam, David B. Solit, Bradley J. Monk
I whakaputaina 2020Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Cancer research
Internal medicine
Medicine
Surgery
Adverse effect
Apoptosis
Biochemistry
Biology
Breast cancer
Cell biology
Chemotherapy
Claudin
Clinical endpoint
Clinical trial
Colorectal cancer
Diarrhea
Doxorubicin
Engineering
Gastroenterology
Gene knockdown
Intraperitoneal injection
Molecular biology
Nausea
Neratinib
Oncology
Operations research
Penetration (warfare)
Peritoneal carcinomatosis
Peritoneal cavity